ELI LILLY & Co is 556.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($1.072 T vs $1.93 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | NKTR | LLY |
|---|---|---|
| Market cap | $1.93 B | $1.072 T |
| US-listed rank | #2118 | #10 |
| Revenue (latest FY) | $55.23M | $65.18B |
| Net income (latest FY) | -$164.00M | $20.64B |
| Net margin | -296.9% | 31.7% |
| P/E (trailing FY) | - | 51.9 |
| SEC filings | 1,949 | 989 |
ELI LILLY & Co is 556.6x more valuable than NEKTAR THERAPEUTICS by market capitalization ($1.072 T vs $1.93 B).
In their latest fiscal years, NEKTAR THERAPEUTICS reported $55.23M in revenue while ELI LILLY & Co reported $65.18B.
Full pages: NEKTAR THERAPEUTICS and ELI LILLY & Co, or browse the full rankings.